ESSENTIAL HYPERTENSION
Clinical trials for ESSENTIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new ESSENTIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for ESSENTIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood pressure combo pill aims to beat standard treatment
Disease control Recruiting nowThis study tests whether a new pill (CKD-202A, combining sacubitril and valsartan) works better than a standard blood pressure medicine (valsartan alone) in adults with essential hypertension. About 324 participants will take either the new combo or the standard drug for a period…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Massive gene hunt aims to solve childhood high blood pressure mystery
Knowledge-focused Recruiting nowThis study aims to find the genes that cause high blood pressure in children and teens. Researchers will study 2300 people, including those with childhood-onset high blood pressure and their healthy relatives. Participants will have yearly checkups, blood and urine tests, and opt…
Matched conditions: ESSENTIAL HYPERTENSION
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated May 17, 2026 02:03 UTC
-
New hypertension drug candidate BCD101 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study tests the safety and tolerability of a new drug called BCD101 in 56 healthy adults. Participants receive either the drug or a placebo, and researchers monitor for side effects and measure how the drug moves through the body. The goal is not to treat high bl…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Bichedam Co., Ltd. • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC